Respiporc Flu3

RSS

inactivated influenza-A virus / swine

Authorised
This medicine is authorised for use in the European Union.

Overview

Respiporc FLU3 is a vaccine that contains 3 different strains of swine influenza A virus which have been inactivated (killed). Respiporc FLU3 is a suspension for injection.

Respiporc FLU3 is used to vaccinate pigs including pregnant sows over the age of 56 days against swine influenza in order to help them clinically but also to reduce the amount of virus present in the lungs. Respiporc FLU3 is also used to vaccinate pregnant sows following their first immunisation by giving them one dose 14 days prior to farrowing in order that the sows milk contains enough antibodies to help protect the piglets against swine influenza for at least 33 days after birth.

This EPAR was last updated on 16/02/2021

Authorisation details

Product details
Name
Respiporc Flu3
Agency product number
EMEA/V/C/000153
Active substance
inactivated influenza-A virus / swine
International non-proprietary name (INN) or common name
  • inactivated influenza-A virus
  • swine
Species
Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QI09AA03
Publication details
Marketing-authorisation holder
CEVA Santé Animale
Revision
5
Date of issue of marketing authorisation valid throughout the European Union
14/01/2010
Contact address

10 avenue de La Ballastière
33500 Libourne
France

Product information

15/09/2020 Respiporc Flu3 - EMEA/V/C/000153 - IG/1256/G

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.

 

Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Immunologicals

Therapeutic indication

Active immunisation of pigs from the age of 56 days onwards, including pregnant sows, against swine influenza caused by subtypes H1N1, H3N2 and H1N2 to reduce clinical signs and viral lung load after infection.

Onset of immunity: 7 days after primary vaccination

Duration of immunity: 4 months in pigs vaccinated between the age of 56 and 96 days and 6 months in pigs vaccinated for the first time at 96 days and above.

Active immunisation of pregnant sows after finished primary immunisation by administration of a single dose 14 days prior to farrowing to develop high colostral immunity, which provides clinical protection of piglets for at least 33 days after birth.

Assessment history

News

How useful was this page?

Add your rating